- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06514924
Secular Change of Height in Turkish Young Adults
Young Turkish Adults Show a Continuing Positive Secular Change of Height But a Worrying Increase of Overweight in Males
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study setting A sample of students was randomly selected from 65,000 students at Istanbul University, originating from every region of Turkey in 2023-2024 (TK2024). The inclusion criteria for the study were: (I) age between 18 and 26 years, (II) being a student at Istanbul University, and (III) volunteering to participate in the study. The exclusion criteria were: (I) diagnosis of a chronic disease, (II) a history of surgery that can affect linear growth, (III) diagnosis of growth retardation, (IV) a history of growth hormone administration, (V) having a parent born outside of Turkey, (VI) birth height or weight less than -2 SDS, and (VII) current height or BMI less than -3 SDS or greater than +3 SDS. This study was approved by the Local Ethical Committee of Istanbul Faculty of Medicine and funded by the Scientific Research Projects Coordination Unit of Istanbul University. Voluntary, informed, written consent was obtained from all the participants. The students' medical history, birthplace, high school graduation province, parental education level and occupation and household income were recorded through a questionnaire.
Measurements Standing height was measured with bare feet using a portable stadiometer and documented to the nearest 0.1 cm. Weight was determined in light clothing using a digital scale and recorded to the closest 0.1 kg. Two trained technicians performed all measurements. Height measurements were repeated twice, and the mean value was calculated. If the difference exceeded 0.3 cm, a third measurement was taken, and the average of the two closest values was used. Body mass index (BMI) was calculated as weight (kg) divided by height (m) square .
Classification of socioeconomic status After collecting all the data, the participants were classified into four groups according to socioeconomic status (SES): SES-1 to 4. SES was determined based on the criteria used in previous national growth studies, which were modified to better align with current conditions. This classification is determined by the educational level of both parents and the father's occupation. Meeting all three criteria was necessary for inclusion in the upper levels of the SES. If any of these criteria are not met, individuals were assigned to a lower SES level.
In the present study, the SES assessment questionnaire is derived from the TK2002 questionnaire, with a single modification: the educational level of parents has been increased by one level. This update is based on data from the Turkish Statistical Institute, which reported a 26% average increase in the duration of education in Turkey between 2008 and 2022.
Comparative Analyses To demonstrate the secular trend, a comparison was made between the data from the present study and the data from the 18-year-old age group in the TK2002 study, which served as the basis for the current national growth curves. The data for 18-year-olds in TK2002 were collected from measurements of senior high school students in six affluent districts of Istanbul. In line with the methodology of the present study, TK2002 also categorized participants into four SES groups based on an SES questionnaire.
The technical specifications and measurement methods of the instruments used in this study are identical to those used in TK2002, ensuring comparability and consistency across both studies.
Adult height and BMI were also compared with TK2002 and with young adults of Turkish origin living in the Netherlands measured in 2009 (NL2009). Age, SES, and geographical region were used to conduct subgroup analyses. Age groups were divided into 18-22 and 23-26 years. Separate subgroups were formed for the seven regions of Turkey based on birthplace or high school graduation.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey
- Istanbul University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
Age:
Participants must be between 18 and 26 years old.
Student Status:
Participants must be current students at Istanbul University.
Voluntary Participation:
Participants must voluntarily agree to participate in the study and provide informed, written consent.
Exclusion Criteria:
Chronic Disease:
Participants with a diagnosis of any chronic disease are excluded.
History of Surgery Affecting Growth:
Participants with a history of any surgery that could affect linear growth are excluded.
Growth Retardation:
Participants with a diagnosis of growth retardation are excluded.
Growth Hormone Administration:
Participants who have received growth hormone treatment are excluded.
Parental Origin:
Participants with a parent born outside of Turkey are excluded.
Birth Height or Weight:
Participants with a birth height or weight less than -2 standard deviations (SDS) are excluded.
Current Height or BMI:
Participants with a current height or BMI less than -3 SDS or greater than +3 SDS are excluded.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
young Turkish males
Aged between 18 - 26 years old Istanbul University students Gender: Male
|
Height and weight measurements and socioeconomic status survey
Other Names:
|
|
young Turkish females
Aged between 18 - 26 years old Istanbul University students Gender: Female
|
Height and weight measurements and socioeconomic status survey
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Mean Adult Height (cm)
Time Frame: 01.09.2023- 01.05.2024
|
Mean height difference in centimeters between the cohorts (Objective: To compare the mean adult height of young Turkish adults in 2023-2024 (TK2024) with those in 2002 (TK2002) and young adults of Turkish origin living in the Netherlands in 2009 (NL2009))
|
01.09.2023- 01.05.2024
|
|
Change in Body Mass Index (BMI, kg/m²)
Time Frame: 01.09.2023- 01.05.2024
|
Mean BMI difference and percentage of participants classified as overweight or obese between the cohorts (Objective: To compare the BMI of young Turkish adults in 2023-2024 (TK2024) with those in 2002 (TK2002) and young adults of Turkish origin living in the Netherlands in 2009 (NL2009)) (BMI was calculated as weight (kg) divided by height (m²), with weight measured using a digital scale (SECA 813, Hamburg, Germany).)
|
01.09.2023- 01.05.2024
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Association between Height and Socioeconomic Status (SES)
Time Frame: 01.05.2024-01.07.2024
|
Comparison of mean height across different SES groups
|
01.05.2024-01.07.2024
|
|
Association between BMI and Socioeconomic Status (SES)
Time Frame: 01.05.2024-01.07.2024
|
Comparison of mean BMI across different SES groups
|
01.05.2024-01.07.2024
|
|
Regional Differences in Height
Time Frame: 01.05.2024- 01.07.2024
|
Mean height differences across regions
|
01.05.2024- 01.07.2024
|
|
Regional Differences in BMI
Time Frame: 01.05.2024 - 01.07.2024
|
Mean BMI differences across regions ()
|
01.05.2024 - 01.07.2024
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Asli Derya Kardelen Al, MD, Istanbul University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ITFPEDENDO1
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
Clinical Trials on height and weight measurement
-
Indonesia UniversityCompletedSevere Acute MalnutritionIndonesia
-
Danone Asia Pacific Holdings Pte, Ltd.KK Women's and Children's HospitalCompletedGrowth; Stunting, NutritionalSingapore
-
University Hospital, Basel, SwitzerlandCompletedDehydration | Hypervolemia | Water Balance DisordersSwitzerland
-
Memorial Sloan Kettering Cancer CenterJohns Hopkins University; St. Jude Children's Research HospitalCompletedAdult Survivors of Childhood LeukemiaUnited States
-
National Taiwan University HospitalActive, not recruitingHypertension | Diabetes Mellitus | Body Weight | Preventive Medicine | Family MedicineTaiwan
-
Northwestern UniversityCompletedPsoriasis | Atopic DermatitisChile, United States, Netherlands, Canada, Hong Kong, Italy
-
University GhentHasselt University; Maastricht UniversityRecruitingGait Analysis | ReproducibilityNetherlands, Belgium
-
Boston UniversityDepartment of Foregin Affairs and Trade, Australia; The Abdul Latif Jameel...Completed
-
Boston UniversityHarvard University; Innovations for Poverty ActionCompletedMalnutrition | Child DevelopmentZambia
-
Universiti Tunku Abdul RahmanCompletedSarcopenia | Sarcopenic Obesity